You are viewing the site in preview mode

Skip to main content

Table 4 Lesion and procedural characteristics

From: Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation

  DM (n = 149) Non-DM (n = 188) p value
Follow-up duration, days 115 ± 29 121 ± 25 0.031
Evidence of ischemia, n (%)    0.006
Exercise tests 6 (4) 12 (6)  
Scintigraphy 25 (17) 17 (9)  
FFR/iFR 12 (8) 4 (2)  
None 106 (71) 155 (82)  
Acute coronary syndrome, n (%) 45 (30) 78 (42) 0.040
Target vessel, n (%)    0.18
Left anterior descend artery 44 (30) 66 (35)  
Left circumflex artery 64 (43) 85 (45)  
Right coronary artery 35 (23) 27 (15)  
Left main trunk 6 (4) 10 (5)  
Heavy calcification, n (%) 17 (11) 19 (10) 0.42
Bifurcation, n (%) 53 (36) 73 (39) 0.31
Chronic total occlusion, n (%) 4 (3) 13 (7) 0.063
ACC/AHA classification, n (%)
 Type A/ B1/ B2/ C 15 (10)/ 26 (17)
/ 24 (16)/ 84 (56)
20 (11)/ 34 (18)
/ 41 (22)/ 93 (50)
0.53
Pre-dilatation balloon
 Maximum diameter, mm 2.63 ± 0.53 2.66 ± 0.52 0.73
 Maximum pressure, atm 13 ± 4 13 ± 3 0.78
 Maximum stent diameter, mm 3.04 ± 0.45 3.12 ± 0.40 0.069
 Minimum stent diameter, mm 2.92 ± 0.43 3.02 ± 0.43 0.030
 Total stent length, mm 31 ± 16 31 ± 20 0.86
 Stent implantation pressure, atm 12 ± 3 12 ± 3 0.85
Post-dilatation balloon
 Maximum diameter, mm 3.20 ± 0.56 3.28 ± 0.65 0.28
 Maximum pressure, atm 17 ± 4 16 ± 4 0.31
 Number of stents 1.2 ± 0.4 1.2 ± 0.4 0.91
Usage of intravascular imaging device, n (%)    0.19
Intravascular ultrasound 118 (79) 162 (86)  
Optical coherence tomography 28 (19) 22 (12)  
None 3 (1) 4 (1)  
Type of DES    0.21
Cypher 1 (1) 2 (1)  
Taxus 0 (0) 1 (1)  
Endeavor 28 (19) 50 (27)  
Xience 30 (20) 32 (17)  
Promus 0 (0) 4 (2)  
Resolute 35 (23) 38 (20)  
Synergy 26 (17) 24 (13)  
Ultimaster 21 (14) 23 (12)  
Orsiro 0 (0) 3 (2)  
BioFreedom 8 (5) 11 (6)  
QCA data    
Pre-PCI    
Minimum lumen diameter, mm 0.95 ± 0.57 0.86 ± 0.57 0.14
Reference diameter, mm 2.65 ± 0.69 2.78 ± 0.80 0.11
Diameter stenosis, % 64 ± 20 70 ± 19 0.020
Lesion length, mm 15 ± 9 17 ± 12 0.13
Post-PCI    
Minimum lumen diameter, mm 2.39 ± 0.52 2.52 ± 0.51 0.028
Reference diameter, mm 2.85 ± 0.55 3.03 ± 0.59 0.005
Diameter stenosis, % 16 ± 8 17 ± 8 0.50
  1. Data are presented as mean ± SD or number (%)
  2. DES  drug-eluting stent, DM diabetes mellitus, FFR  fractional flow reserve, iFR  instantaneous wave-free ratio, PCI  percutaneous coronary intervention, QCA  quantitative coronary angiography